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ABSTRACT
Nuclear protein HMGB1 is secreted in response to various stimuli and functions as a danger-associated 
molecular pattern. Extracellular HMGB1 induces inflammation, cytokine production, and immune cell 
recruitment via activation of various receptors. As HMGB1 does not contain an endoplasmic reticulum- 
targeting signal peptide, HMGB1 is secreted via the endoplasmic reticulum-Golgi independently via an 
unconventional secretion pathway. However, the mechanism underlying HMGB1 secretion remains 
largely unknown. Here, we investigated the role of secretory autophagy machinery and vesicular 
trafficking in HMGB1 secretion. We observed that HSP90AA1 (heat shock protein 90 alpha family class 
A member 1), a stress-inducible protein, regulates the translocation of HMGB1 from the nucleus to the 
cytoplasm and its secretion through direct interaction. Additionally, geldanamycin, an HSP90AA1 
inhibitor, reduced HMGB1 secretion. GORASP2/GRASP55 (golgi reassembly stacking protein 2), 
ARF1Q71L (ADP ribosylation factor 1), and SAR1AT39N (secretion associated Ras related GTPase 1A), 
which promoted unconventional protein secretion, increased HMGB1 secretion. HMGB1 secretion was 
inhibited by an early autophagy inhibitor and diminished in ATG5-deficient cells even when GORASP2 
was overexpressed. In contrast, a late autophagy inhibitor increased HMGB1 secretion under the same 
conditions. The multivesicular body formation inhibitor GW4869 dramatically decreased HMGB1 secre-
tion under HMGB1 secretion-inducing conditions. Thus, we demonstrated that secretory autophagy and 
multivesicular body formation mediate HMGB1 secretion.
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HMGB1 (high mobility group box 1), identified as a non- 
histone nuclear protein, is a DNA chaperone that repairs and 
stabilizes the chromatin structure [1,2]. HMGB1 plays impor-
tant roles in macroautophagy/autophagy and metabolism and 
is secreted into the extracellular fluid in response to various 
stimuli, where it acts as a danger-associated molecular pattern 
to induce sterile inflammation and cell migration [3,4]. In 
HMGB1 secretion, which is inflammasome-mediated and 
involves an autophagy-regulated mechanism, post- 
translational modifications of acetylation, phosphorylation, 
and N-linked glycosylation are involved [5–13]. HMGB1 
translocation from the nucleus to the cytoplasm is regulated 
by the nuclear export protein XPO1/CRM1 [8]. However, the 
specific molecular mechanism of HMGB1 secretion is 
unknown.
Most eukaryotic proteins are secreted through the conven-
tional endoplasmic reticulum (ER)-Golgi secretory pathway. 
These proteins contain signal peptides for being targeted into 
the ER. However, some proteins are secreted via an ER-Golgi 
independent pathway known as unconventional protein secre-
tion (UCPS). Unconventionally secreted proteins are generally 
involved in immune surveillance, cell survival, and cellular 
stress [14]. In addition, the UCPS pathway includes various 
mechanisms. Type I secretion involves the direct, pore- 
mediated translocation of a cytoplasmic protein across the 
plasma membrane without the formation of vesicular inter-
mediates. The most well-studied protein that uses this type of 
secretion is FGF2 (fibroblast growth factor 2). Membrane 
translocation of this protein is promoted by a self-sustained 
mechanism driven by PtdIns(4,5)P2-dependent oligomeriza-
tion [15]. Type II secretion systems involve ABC transporters, 
which are used to translocate lipidated peptides and proteins. 
Type III secretion involves autophagosome/endosome-based 
secretion mediated by intracellular vesicles, such as secretory 
lysosomes, microvesicles, and multivesicular bodies (MVBs). 
The secretion of IL1B/IL-1β (interleukin 1 beta) is one of the 
most widely studied examples of type III secretion. IL1B 
secretion depends on CASP1 (caspase 1)-dependent proteoly-
tic cleavage mediated by intracellular inflammasome 
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activation [16]. Recently, ATG5 (autophagy related 5), the 
small GTPase RAB8A, and GORASP2/GRASP55 (golgi reas-
sembly stacking protein 2) were found to be involved in IL1B 
secretion [17]. Type IV secretion systems, for the Golgi- 
bypass secretion of plasma membrane resident proteins, use 
a classical secretory pathway. The secretion of transmembrane 
proteins involves anterograde transport from the ER to the 
plasma membrane without passage through the Golgi com-
plex [14,18,19].
Autophagy is a process that mediates the clearance of 
cellular components, such as lipids, aggregated proteins, and 
damaged organelles, which are recycled to maintain cellular 
homeostasis. Autophagy not only functions in protein degra-
dation but also protein secretion. The autophagy-mediated 
protein secretion mechanism is known as secretory autopha-
gy. This mechanism is not well-understood; however, it 
reportedly differs from degradative autophagy-based on the 
participation of specific proteins, Grh1 (yeast ortholog of the 
mammalian Golgi reassembly stacking protein 1), Bug1, and 
endosomal sorting complexes required for transport 
(ESCRT)-II and -III proteins for the biogenesis of the com-
partment of UCPS in yeast. The GORASP family (GORASP1/ 
GRASP65 and GORASP2/GRASP55) is crucial for the uncon-
ventional secretion of cytoplasmic proteins and Golgi-bypass 
proteins [20]. GORASP proteins are found on the stacks of 
Golgi cisternae and function to tether vesicles for fusion with 
the Golgi apparatus. GORASPs depletion appears to impair 
protein trafficking and disrupt the Golgi structure [21]. 
Moreover, GORASP proteins induce the formation of the 
compartment of UCPS in yeast and promote IL1B secretion 
from macrophages [17,19].
As a stress-inducible protein, HSP90AA1 (heat shock pro-
tein 90 alpha family class A member 1) functions as a protein 
chaperone of misfolded proteins to maintain cell homeostasis. 
HSP90AA1 regulates the stability and activity of protein 
kinases, transcription factors, and cell signaling proteins 
under normal and stress conditions [22,23]. Additionally, 
HSP90AA1 regulates UCPS of IL1B by facilitating the entry 
of IL1B into vesicles [24].
In this study, we investigated the role of HSP90AA1 in the 
nucleo-cytoplasmic shuttling and secretion of HMGB1. To the 
best of our knowledge, this is the first report indicating that 
HMGB1 could bind to HSP90AA1. Our data demonstrate that 
secretory autophagy machinery and vesicular trafficking com-
ponents participate in the unconventional secretion of 
HMGB1 using GORASP2, SAR1AT39N, and ARF1Q71L and 
MVB formation.
Results
HSP90AA1 binds to HMGB1, resulting in its secretion
The function of HMGB1 is altered when it interacts with 
specific binding partners [25]. To search for novel binding 
partners of HMGB1, human embryonic kidney (HEK) 293 T 
cells were first transfected with MYC/cMyc-HMGB1, and then 
whole-cell lysates (WCLs) were pulled-down using MYC affi-
nity beads. HMGB1-binding molecules, including HSP90AA1, 
were analyzed by mass spectrometry (Fig. S1A). HSP90AA1 
was found to interact with HMGB1 through exogenous trans-
fection analysis using immunoprecipitation (IP) and proxi-
mity ligation assay (PLA) (Figure 1A and S1B). The 
endogenous binding of HMGB1 to HSP90AA1 was detected 
under starvation conditions in Earle’s balanced salt solution 
(EBSS) by IP and PLA (Figure 1B and 1C). The interaction 
between HMGB1 and HSP90AA1 was mostly observed in the 
nucleus. Subdomain analysis of HSP90AA1 showed that 
HMGB1 was bound to both the HSP90AA1 N-terminal 
domain (NTD) and the middle domain (MD) but not the 
C-terminal domain (CTD) (Figure 1D and S1C). In contrast, 
HSP90AA1 interacted with wild type (WT) HMGB1 and the 
C-tail deletion mutant (ΔC) (Figure 1E and S1C). We 
observed a direct interaction between HMGB1 and 
HSP90AA1 by enzyme-linked immunosorbent assay (ELISA) 
and in vitro binding assay (Figure 1F and S1D).
Nuclear HSPA7/HSP70/HSP72, another HSP family pro-
tein, suppresses HMGB1 nucleo-cytoplasmic translocation 
under oxidative stress or mild heat shock conditions [26]. 
When HEK293T cells were co-transfected with HMGB1-GFP 
and HSP90AA1-Flag, HMGB1 was mostly localized in the 
cytoplasm, regardless of whether starvation stress was present 
or absent; this localization was inhibited by geldanamycin 
(GA), an HSP90AA1 inhibitor (Figure 2A). Previously, we 
demonstrated that oxidation of HMGB1 to form an intramo-
lecular disulfide bond between C23 and C45 is a prerequisite 
for its nucleo-cytoplasmic translocation [27]. The HMGB1C23S 
mutant, however, was observed in the nucleus upon 
HSP90AA1 overexpression (Fig. S2A), although the interac-
tion between HSP90AA1 and HMGB1C23S was similar to that 
with WT HMGB1 (Fig. S2B). These data indicate that 
HSP90AA1 binds to HMGB1 in the nucleus and facilitates 
its nucleo-cytoplasmic translocation.
Overexpression of the HSP90AA1 NTD and MD induced 
cytoplasmic translocation of HMGB1 in HEK293T cells 
(Figure 2B). HMGB1 secretion was increased by HSP90AA1 
overexpression and decreased by HSP90AA1 knockdown or 
GA treatment under starvation conditions (Figure 2(C-E)). 
The phosphorylation and acetylation of HMGB1 caused by 
phorbol 12-myristate 13-acetate (PMA) and trichostatin 
A (TSA) treatments, respectively, induce HMGB1 secretion 
[7,8]. These effects were inhibited by GA (Fig. S2C), indicat-
ing that HSP90AA1 is important for HMGB1 translocation 
and secretion.
HSP90AA1 increases the binding of HMGB1 to XPO1
HSP90AA1 promotes the cytoplasmic translocation of MTA1 
(metastasis associated 1) along with the nuclear export protein 
XPO1 [28]. HSP90AA1 interacts with XPO1 to facilitate its 
nucleo-cytoplasmic translocation [29]. Cytoplasmic transloca-
tion of HMGB1 is mediated by XPO1 [8]. We hypothesized 
that HSP90AA1 increased the interaction between HMGB1 
and XPO1. HSP90AA1 overexpression increased the binding 
of HMGB1 to XPO1 (Figure 2C), and the HSP90AA1 NTD 
and MD increased the binding between HMGB1 and XPO1 
(Figure 3A). The specific binding and the nucleo-cytoplasmic 
translocation of HMGB1 were inhibited by leptomycin 
B (LMB), a XPO1 inhibitor (Figure 3(B,C)). These results 
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indicate that HSP90AA1 promotes the interaction between 
HMGB1 and XPO1 for cytoplasmic translocation of HMGB1.
GORASP2 increases HMGB1 secretion
The GORASP2-dependent autophagy machinery plays a vital 
role in the secretion of leaderless proteins, such as IL1B [17]. 
We thus next investigated the secretory autophagy machinery 
involved in HMGB1 secretion. GORASP has two isoforms: 
GORASP1 and GORASP2. GORASP1 is involved in the early 
stage of ER to Golgi transport, and GORASP2 is sensitive to 
cargo-related transport [30]. Thus, we focused on the role of 
GORASP2 in HMGB1 secretion. When GORASP2 was over-
expressed in HEK293T cells, HMGB1 secretion was augmented 
by starvation and PMA- and TSA-treated conditions (Figure 4A 
and S3A), and knockdown of GORASP2 reduced HMGB1 
secretion (Figure 4B). We next evaluated how GORASP2 
increases HMGB1 secretion. GORASP2 showed no binding to 
HMGB1 in our study (Fig. S3B), but GORASP2 overexpression 
induced the cytoplasmic localization of HMGB1 (Fig. S3C), 
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Figure 1. HSP90AA1 interacts with HMGB1. (A) HEK293T cells were co-transfected with MYC-HMGB1 and HSP90AA1-Flag and incubated for 48 h. WCLs were 
immunoprecipitated (IP) against MYC, and immunoblotted (IB) with anti-Flag, anti-MYC, and anti-ACTB antibodies. (B) The cells were treated with EBSS for 6 h. WCLs 
were immunoprecipitated with anti-HSP90 and anti-HMGB1 antibodies and immunoblotted with anti-HMGB1 and anti-HSP90, and anti-ACTB antibodies. (C) HEK293T 
cells were treated with EBSS for 6 h, and the interaction between HMGB1 and HSP90AA1 was observed using PLA. Scale bar: 5 μm. (D, E) To observe the interactions 
between HMGB1 (Boxes A and B, and ΔC-HMGB1) and HSP90AA1 domains [W (Wild type), N (N-terminal domain), M (middle domain), and C (C-terminal domain)- 
Flag], HEK293T cells were transfected for 48 h, and WCLs were immunoprecipitated and immunoblotted. Arrowhead: HSP90AA1 MD. (F) Recombinant HSP90AA1 was 
coated on the polystyrene microplate for 18 h, and serially diluted recombinant HMGB1 was added for 1 h for ELISA. BSA was used as a control protein. Data are 
presented as the mean ± SEM from at least three independent experiments. n.s.: not significant, *p < 0.001, compared to each control, two-tailed unpaired Student’s 
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Figure 2. HSP90AA1 increases HMGB1 secretion by promoting HMGB1 cytoplasmic translocation. (A, B) HEK293T cells were co-transfected with HMGB1-GFP and 
HSP90AA1-Flag or HMGB1-GFP and HSP90AA1 WT, NTD, MD, or CTD-Flag. After 48 h, the cells were treated with 0.5 μM geldanamycin (GA) and EBSS for 6 h. The cells 
were immunostained with anti-Flag antibody (red). Subcellular localization of HMGB1 was observed using a confocal microscope. Scale bar: 5 μm. The number of 
cytoplasmic HMGB1-positive cells was counted among over 200 GFP-positive cells. (C) MYC-HMGB1 and HSP90AA1-Flag were transfected into HEK293T cells. WCLs 
were performed IP using anti-MYC antibody and immunoblotting with anti-MYC, anti-Flag, anti-XPO1, and anti-ACTB antibodies. The culture supernatants were 
concentrated with Amicon Centricon filters. (D) HEK293T cells were transiently transfected with shRNA control (SHC001) or shHSP90AA1 (#1; TRCN0000315007 and #2; 
TRCN0000315009). After 48 h, the cells were incubated in EBSS for 14 h. Immunoblotting was performed as indicated. (E) HEK293T cells were pretreated with dose- 
dependently GA treatment for 2 h. The cells were incubated in EBSS media for 14 h. WCLs were immunoblotted with anti-HMGB1 and anti-ACTB antibodies. The 
culture supernatants were concentrated with Amicon Centricon filters. Data are presented as the mean ± SEM from at least three independent experiments. n.s.: not 
significant, *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA analysis of variance followed by Tukey honestly significant difference posthoc test for multiple 
comparisons.
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secretion. PRDX2 (peroxiredoxin 2) was used as a positive 
control molecule for HMGB1 binding [27].
We tested the interaction between HSP90AA1 and GORASP2 
using IP to confirm the correlation between HSP90AA1 and 
GORASP2 because both HSP90AA1 and GORASP2 increased 
HMGB1 secretion according to our previous results. However, 
no direct interaction was observed (Fig. S3D). HMGB1 secre-
tion, however, showed a greater increase when both HSP90AA1 
and GORASP2 were exogenously co-expressed and decreased by 
GA treatment (Figure 4(C,D)). Thus, HSP90AA1 and GORASP2 
synergistically promoted HMGB1 secretion.
The autophagy machinery regulates HSP90AA1 and 
GORASP2-mediated HMGB1 secretion
HMGB1 secretion is related to secretory autophagy [6,17,31], 
and both HSP90AA1 and GORASP2 are related to autophagy 
formation [17,32]. We tested the autophagy machinery induced 
by HSP90AA1 and GORASP2 for HMGB1 secretion. 
Autophagosome formation was increased by GORASP2 over-
expression and decreased by GA treatment in the presence of 
chloroquine (CQ) (Fig. S4A and S4B), suggesting that 
HSP90AA1 and GORASP2 induce autophagy flux. 
Colocalization of HMGB1 and MAP1LC3/LC3 (microtubule- 
associated protein 1 light chain) was increased by either 
HSP90AA1 or GORASP2 overexpression according to confocal 
microscopy analysis and IP assay (Figure 5(A-C) and S4C). 
These results indicate that both HSP90AA1 and GORASP2 
increase autophagy flux and promote HMGB1 and LC3 coloca-
lization. HMGB1 secretion was inhibited by the early autophagy 
inhibitor wortmannin (Wort) but promoted by the late autopha-
gy inhibitors Baf and CQ [33] under starvation or PMA treat-
ment (Figure 5(D,E), and S4D); the increase in secretion was 
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Figure 3. XPO1 influences HSP90AA1-mediated HMGB1 cytoplasmic translocation. (A) MYC-HMGB1 and HSP90AA1 W (Wild type), N (N-terminal domain), M (middle 
domain), and C (C-terminal domain)-Flag were transfected into HEK293T cells. WCLs were evaluated by IP using anti-MYC antibody and immunoblotted using anti- 
MYC, anti-Flag, anti-XPO1, and anti-ACTB antibodies. Culture supernatants were concentrated with Amicon Centricon filters. (B) HEK293T cells were transfected with 
HMGB1-GFP and HSP90AA1-Flag for 24 h and then treated with 20 ng/mL LMB for 24 h. The cells were immunostained with anti-Flag antibody (red). The localization 
of HMGB1 was observed using a confocal microscope. Scale bar: 5 μm. The number of cytoplasmic HMGB1-positive cells was counted among over 200 GFP-positive 
cells. n.s.: not significant, *p < 0.001. (C) HEK293T cells were transfected with MYC-HMGB1 and HSP90AA1-Flag. The cells were pretreated with 30 ng/mL LMB for 1 h 
and incubated in EBSS media for 6 h. WCLs were immunoprecipitated with anti-MYC antibody and immunoblotted with anti-XPO1, anti-Flag, anti-MYC, and anti- 
ACTB antibodies.
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HMGB1 secretion was detected in WT mouse embryonic 
fibroblasts (MEFs) under CQ treatment or starvation con-
ditions but dramatically decreased in atg5−/- MEF cells (Fig. 
S4F and S4G). GORASP2 overexpression also showed no 
influence of HMGB1 secretion in atg5−/- MEF cells (Figure 
5F). These results suggest that HMGB1 secretion is regu-
lated by both HSP90AA1- and GORASP2-mediated secre-
tory autophagy machinery involving autophagosome 
formation and maturation but not by autophagosome- 
lysosome fusion.
Next, we tested whether HMGB1 secretion requires extracel-
lular vesicle (EV) loading during GORASP2-autophagy- 
mediated secretion. Culture supernatants were collected from 
WT MEF and atg5−/- MEF cells (Figure 5G) and WT mouse 
bone marrow-derived macrophages (BMDM) and gorasp2−/- 
BMDM after EBSS or LPS treatment (Fig. S5A). After separating 
EVs from the culture supernatant by a differential ultracentrifu-
gation series, EVs were exposed to proteinase K with or without 
Triton X-100 to observe HMGB1 loading in EVs. Proteinase K is 
expected to digest HMGB1 in the presence of Triton X-100, 
A B
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Figure 4. GORASP2 increases HMGB1 secretion. (A, B) HEK293T cells were transfected with GORASP2-MYC, shRNA control (SHC001) or shGORASP2 (#1; 
TRCN0000129348 and #2; TRCN0000127611). The cells were incubated in EBSS media for 14 h. WCLs were immunoblotted with anti-MYC, anti-HMGB1, anti- 
GORASP2, and anti-ACTB antibodies. The culture supernatants were concentrated with Amicon Centricon filters. (C) GORASP2-MYC and HSP90AA1-Flag were 
transfected into HEK293T cells. WCLs were immunoblotted with anti-MYC, anti-Flag, anti-HMGB1, and anti-ACTB antibodies. Culture supernatants were concentrated 
with Centricon filters. Results were compared to those for co-expressed HSP90AA1 and GORASP2/GRASP55. (D) GORASP2-MYC was transfected and treated with 
0.5 μM GA for 24 h. WCLs were immunoblotted with anti-MYC, anti-HMGB1, and anti-ACTB antibodies. Culture supernatants were concentrated with Centricon filters. 
Data are presented as the mean ± SEM from at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA followed by Tukey 
honestly significant difference posthoc test for multiple comparisons.




















Vector - + - + -
GORASP2 - - + - +












Empty vector - + - + -
- - + - +






























Baf - + - + - + - +










































Empty vector + - + -
































+ + + - - -
- - - + + +
EBSS+Baf+CQ + + + + + +
+ + + +
+ +
- -









































































































Figure 5. Autophagy machinery regulates HSP90AA1 and GORASP2-mediated HMGB1 secretion. (A) HEK293T cells were transfected with HMGB1-mCherry, GFP-LC3, 
GORASP2-MYC, and HSP90AA1-Flag for 48 h, and treated with 20 μM CQ under EBSS treatment for 4 h. The cells were permeabilized with 20 μg/mL digitonin buffer in 
PBS on ice for 5 min. The cells were immunostained with anti-Flag and anti-MYC antibodies. (B) Quantification analysis of co-localization of HMGB1 and LC3. Scale 
bar: 5 μm. (C) HEK293T cells were transfected with HSP90AA1-Flag and treated with 20 μM CQ under EBSS treatment for 4 h. WCLs were immunoprecipitated with 
anti-HMGB1 antibody and immunoblotted with anti-LC3, anti-Flag, anti-HMGB1, and anti-ACTB antibodies. (D) HEK293T were pretreated with 100 nM wortmannin 
(Wo), 20 nM bafilomycin A1 (Baf), and 20 μM chloroquine (CQ) for 2 h and incubated in EBSS media for 14 h. WCLs were immunoblotted with anti-HMGB1, anti-LC3, 
and anti-ACTB antibodies. Culture supernatants were concentrated with Centricon filters. All results were compared to EBSS treatment alone. (E) The cells were 
pretreated with 0.5 μM GA for 2 h and then treated with 20 nM Baf and 350 nM PMA for 24 h. Immunoblotting was performed against anti-HMGB1 and anti-ACTB 
antibodies. (F) ATG5-inducible Tet-off MEF cells were cultured in presence and absence 1 μg/mL doxycycline for 48 h to generate atg5 knockout (atg5−/- MEF) cells. 
atg5 knockout cells were transfected with GORASP2-MYC. The cells were incubated in EBSS media for 14 h. WCLs were immunoblotted with anti-HMGB1, anti-LC3, 
anti-ATG5, anti-MYC, and anti-ACTB antibodies. The culture supernatants were concentrated with Centricon filters. Results were compared to those obtained using 
WT MEF cells. (G) EVs of WT MEF and atg5−/- MEF cells were treated with 20 μg/mL proteinase K with or without 1% Triton X-100 (TX-100) for 1 h at 37°C, and 
HMGB1 protection in EVs was evaluated by immunoblotting. EVs were immunoblotted with anti-HMGB1, anti-LC3, anti-TSG101, anti-PDCD6IP/Alix, and anti-ACTB 
antibodies. (A-F) Data are presented as the mean ± SEM from at least three independent experiments. n.s.: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, one- 
way ANOVA followed by Tukey honestly significant difference posthoc test for multiple comparisons.
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which releases HMGB1 from EVs through disintegrating the 
membrane. HMGB1 could be detected in proteinase K-treated 
EVs from WT MEF cells and WT BMDM cells in the absence of 
Triton X-100 and was not nearly detected in the presence of 
Triton X-100, indicating that HMGB1 was present inside EVs 
(Figure 5G and S5A). The levels of HMGB1 loading in EVs of 
atg5−/- MEF cells and gorasp2−/- BMDM were significantly 
reduced compared to those in WT MEF cells and WT BMDM 
cells, respectively (Figure 5G and S5A). These results indicate 
that GORASP2- and autophagy-mediated HMGB1 secretion 
play a vital role in EV loading.
A recent study suggested that autophagy-mediated uncon-
ventional secretion via EVs requires LC3 conjugation machin-
ery, such as ATG7 and ATG12, called “LC3-dependent EV 
loading and secretion (LDELS)” [34]. In our study, HMGB1 
secretion was reduced in the knockdowns of LC3 conjugation 
elements, namely ATG7 and ATG12, in starvation conditions 
(Fig. S5B and S5C). ATG14 plays a vital role in the initiation 
process of BECN1 (beclin 1) and phosphatidylinositol-3 
kinase (PtdIns3K) complex-associated autophagy [35]. 
Besides, HMGB1 secretion was decreased in ATG14 knock-
down cells and atg14−/- HCT116 cells under the EBSS condi-
tion (Fig. S5D and S5E). Moreover, we observed that 
HMGB1 secretion was inhibited by the early autophagy inhi-
bitor of Wort upon either EBSS or PMA treatment (Figure 5D 
and S4D). These results indicate that autophagy-mediated 
HMGB1 secretion is dependent on the initiation and LC3 
conjugation steps during autophagy execution.
SAR1A and ARF1 dominant-negative mutants enhance 
HMGB1 secretion via secretory autophagy pathway
SAR1A (secretion-associated Ras-related GTPase 1A) and 
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Figure 6. Small G protein SAR1A and ARF1 dominant-negative mutants participate in HMGB1 secretion by promoting secretory autophagy-mediated secretion 
pathway. (A-D) HEK293T cells were transfected with MYC-SAR1AT39N and HA-ARF1Q71L. The cells incubated in EBSS for 14 h (A, B), 350 nM PMA (C), and 0.5 μM GA (D) 
for 24 h. WCLs and culture medium were evaluated using anti-HMGB1, anti-MYC, anti-HA, and anti-ACTB antibodies. (E) HEK293T cells were transiently transfected 
with MYC-SAR1AT39N and HA-ARF1Q71L and treated with 20 μM CQ for 24 h. WCLs were examined by immunoblotting against anti-LC3, anti-HMGB1, anti-MYC, anti-HA, 
and anti-ACTB antibodies. (F, G) HEK293T transfected with MYC-SAR1AT39N (F), and HA-ARF1Q71L (G) were treated with 100 nM Wo, 20 nM Baf, and 20 μM CQ for 24 h. 
WCLs and culture supernatants were evaluated by immunoblotting against anti-LC3, anti-HMGB1, anti-MYC, anti-HA, and anti-ACTB antibodies. Data are presented as 
the mean ± SEM from at least three independent experiments. n.s.: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA followed by Tukey honestly 
significant difference posthoc test for multiple comparisons.
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Figure 7. MVB formation is crucial in HMGB1 secretion. (A) HEK293T cells were transiently transfected with shRNA control (SHC001), shHGS (TRCN0000379833), and 
shTSG101 (TRCN0000315042) for 24 h. The cells were treated with 20 μM CQ, 350 nM PMA, and 25 ng/mL TSA for 24 h and with EBSS for 14 h. Culture supernatants 
and WCLs were immunoblotted with anti-HMGB1, anti-HGS, anti-TSG101, and anti-ACTB antibodies. All results were compared to that for the shRNA control for each 
treatment. (B, C) HEK293T cells pretreated with 2 μM GW4869 for 2 h, and treated with 350 nM PMA and 25 ng/mL TSA for 24 h, and EBSS for 14 h (B); 100 nM Wo, 
20 nM Baf, and 20 μM CQ for 24 h (C). WCLs and supernatants were immunoblotted with anti-HMGB1 and anti-ACTB antibodies. (D, E) HEK293T cells were transfected 
with HSP90AA1-Flag and GORASP2-MYC (D); HA-ARF1Q71L (E) for 24 h. The cells were treated with 2 μM GW4869 for 24 h. Culture supernatants and WCLs were 
immunoblotted with anti-HMGB1, anti-HA, and anti-ACTB antibodies. (F) HEK293T cells were transiently transfected with shRNA control, shRAB7A (TRCN0000229643), 
shRAB8A (TRCN0000048216), shRAB11A (TRCN0000073021), and shRAB27A (TRCN0000005295) for 24 h. The cells were treated with 20 μM CQ for 24 h. Culture 
supernatants were immunoblotted with anti-HMGB1 antibodies. All results were compared to those of the shRNA control treated with CQ. Data are presented as the 
mean ± SEM from at least three independent experiments. n.s.: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA followed by Tukey honestly 
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Figure 8. HMGB1 secretion is regulated by autophagy-mediated secretion in macrophages. (A) RAW264.7 cells were pretreated with 100 nM Wo, 20 nM Baf, 20 μM 
CQ for 2 h, and treated with 250 ng/mL LPS for 24 h. WCLs and supernatants were immunoblotted with anti-HMGB1, anti-LC3, and anti-ACTB antibodies. (B) 
RAW264.7 cells were pretreated with 2 μM GW (GW4869) for 2 h and treated with 250 ng/mL LPS and 50 μM H2O2 for 24 h. WCLs and supernatants were 
immunoblotted with anti-HMGB1, anti-IL1B, and anti-ACTB antibodies. (C) RAW264.7 cells were pretreated with 100 nM Wo, 20 nM Baf, 20 μM CQ for 2 h, and treated 
with 250 ng/mL LPS for 24 h. TNF levels were measured in the culture supernatants by ELISA. All results were compared to those of LPS treatment alone. (D) 
RAW264.7 cells were pretreated with 2 μM GW4869 for 2 h and then treated with 250 ng/mL LPS and 50 μM H2O2 for 24 h. TNF level in the supernatants was 
measured by ELISA. (E) THP-1 cells were pretreated with 2 μM GW4869 for 2 h and treated with 20 μM CQ and 300 ng/mL LPS for 24 h. WCLs and supernatants were 
immunoblotted with anti-HMGB1, anti-IL1B, and anti-ACTB antibodies. (F) BMDMs were pretreated with 2 μM GW4869 for 2 h, and treated with 250 ng/mL LPS for 
24 h. WCLs and supernatants were immunoblotted with anti-HMGB1, anti-IL1B, anti-CASP1, and anti-ACTB antibodies. (G) WT BMDM and gorasp2−/- BMDM cells were 
pretreated with 0.5 μM GA for 2 h and treated with 250 ng/mL LPS for 24 h. WCLs and culture supernatants were immunoblotted with anti-GORASP2, anti-HMGB1, 
and anti-ACTB antibodies. Culture supernatants were concentrated with Centricon filters. Data are presented as the mean ± SEM from at least three independent 
experiments. n.s: not significant, *p < 0.05, **p< 0.01, ***p < 0.001, one-way ANOVA followed by Tukey honestly significant difference posthoc test for multiple 
comparisons.
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vesicle-coated protein complexes COP I and II, respectively, 
are small G proteins that play a critical role in conventional 
ER-to-Golgi trafficking. The blockade of ER-to-Golgi traffick-
ing by dominant inhibitory forms of SAR1A and ARF1 
mutants, which induce ER stress and the unfolded protein 
response, has also been shown to evoke unconventional cell- 
surface trafficking of CFTR (cystic fibrosis transmembrane 
conductance regulator) and SLC26A4/pendrin [36–39]. We 
next investigated the effect of SAR1A and ARF1 DN (domi-
nant-negative) mutants (SAR1AT39N and ARF1Q71L) on 
HMGB1 secretion. HMGB1 secretion was increased by over-
expression of either SAR1AT39N or ARF1Q71L (Figure 6 
(A-D)), which was inhibited by GA treatment (Figure 6D). 
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Figure 9. Physiological relevance and proposed model of HMGB1 secretion. (A) WT and gorasp2−/- mice were injected intraperitoneally with 2 mg/kg LPS, and blood 
samples were collected after 16 h. HMGB1 concentration was measured from obtained sera. N = 5 mice per group (one gorasp2−/- mouse was dead after LPS 
injection). Data are presented as the mean ± SEM from at least three independent experiments. *p < 0.01, **p < 0.001, one-way analysis of variance followed by 
Tukey honestly significant difference posthoc test for multiple comparisons. (B, C) WT MEF, hmgb1−/- MEF, and atg5−/- MEF cells were pretreated with 2 μM GW4869 
for 2 h and then treated with 50 μM H2O2 and 30 μM CQ for 24 h. The culture supernatants were used to treat RAW264.7 cells at a 1:10 ratio for 6 h. Levels of TNF 
and IL6 were measured by ELISA. All data are presented as the mean ± SEM from at least three independent experiments. **p < 0.001, one-way ANOVA followed by 
Tukey honestly significant difference posthoc test for multiple comparisons. (D) Model of autophagy machinery and MVB-mediated HMGB1 secretion mechanism. 
Under normal conditions, HMGB1 resides in the nucleus. Under stress conditions, (1) HMGB1 is transferred by HSP90AA1 and XPO1 from the nucleus to the 
cytoplasm. (2) Autophagy machinery induced by GORASP2, ARF1T39N, and SAR1AQ71L is engulfed cytosolic HMGB1 into phagophore. (3) Completely closed 
autophagosome is fused on lysosome (degradation) or MVB (secretion). (4) Under the blockade of autophagosome and lysosome fusion, HMGB1 secretion is 
elevated via an MVB-dependent pathway. (5) MVB formation is blocked, and HMGB1 secretion is diminished. (6) RAB8A, RAB11A, or RAB27A-mediated vesicle 
trafficking regulates HMGB1 secretion. Autophagy-based unconventional secretory pathway for extracellular delivery could be observed for IL1B and IL18 [17], 
supporting this model.
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HMGB1 secretion, we tested whether HMGB1 secretion 
induced by SAR1A and ARF1 DN mutants depends on the 
autophagy-based UCPS pathway. LC3-II level was more 
increased by CQ treatment when SAR1AT39N or ARF1Q71L 
was overexpressed (Figure 6E). HMGB1 secretion by 
SAR1AT39N and ARF1Q71L overexpression was suppressed by 
Wort treatment but enhanced by Baf and CQ treatments 
(Figure 6(E-G)), indicating that SAR1AT39N and ARF1Q71L 
enhance HMGB1 secretion in an autophagy-dependent 
manner.
MVB formation regulates HMGB1 secretion
MVBs are a type of late endosome containing unique mem-
brane-enclosed structures with intraluminal vesicles. MVBs 
are involved in various functions, such as receptor internali-
zation, protein secretion, and lysosomal degradation [40]. 
Protein secretion regulated by the autophagy machinery 
involves specific vesicles (amphisome) fused on MVBs and 
autophagosomes [41]. We hypothesized that HMGB1 is 
secreted via an MVB-dependent pathway. MVB formation 
involves two types of machinery; ESCRT protein complex- 
dependent and ESCRT-independent machinery, also known 
as ceramide-dependent machinery. To investigate whether the 
ESCRT protein complex influences HMGB1 secretion, short 
hairpin RNAs (shRNAs) against ESCRT-related genes (HGS 
and TSG101) were transiently overexpressed in HEK293T 
cells to observe HMGB1 secretion. HMGB1 secretion was 
reduced by shHGS and shTSG101 upon CQ, PMA, TSA, 
and EBSS treatment (Figure 7A). Following treatment in 
HEK293 cells with GW4869, which is a SMPD3/nSMase2 
(sphingomyelin phosphodiesterase 3) inhibitor used to inhibit 
ceramide-dependent MVB formation [42,43], HMGB1 secre-
tion was decreased under PMA, TSA, starvation, Baf, and CQ 
treatments (Figure 7(B,C)). HMGB1 secretion induced by 
HSP90AA1, GORASP2, and ARF1Q71L overexpression was 
decreased by GW4869 treatment (Figure 7(D,E)). These 
results indicate that HMGB1 secretion is regulated by 
ESCRT and a ceramide-dependent MVB secretion pathway.
RAB proteins play critical roles in vesicular trafficking and 
membrane fusion, including in autophagy. RAB8A and 
RAB27A participate in ANXA2 (annexin A2) exophagy [44]. 
RAB7A is involved in MVB and lysosome fusion, and 
RAB11A and RAB27A are known to induce components 
involved in exosome secretion [40,45–47]. Knockdown of 
each of RAB8A, RAB11A, and RAB27A in HEK293T cells 
dramatically decreased HMGB1 secretion upon CQ treatment, 
but RAB7A knockdown did not (Figure 7F).
Autophagy machinery and MVB formation induce HMGB1 
secretion in macrophages
Our data showed that HMGB1 secretion is regulated by auto-
phagy machinery and MVB formation in HEK293T cells. 
When we tested HMGB1 secretion using the RAW264.7 
macrophage cell line, HMGB1 secretion was decreased by pre- 
treatment with Wort but increased by pre-treatment with Baf 
and CQ under LPS stimulation (Figure 8A). GW4869 
decreased HMGB1 secretion under LPS and H2O2 treatment 
(Figure 8B and S6). In contrast, the level of TNF (tumor 
necrosis factor), which is secreted via the conventional secre-
tion pathway, showed no significant difference following 
treatment with the different autophagy inhibitors (Wort, 
Baf, and CQ) and GW4869 (Figure 8(C,D)). IL1B, 
a representative unconventional secreted protein, showed 
a similar secretion pattern as HMGB1 (Figure 8B). The 
human macrophage cell line THP-1 showed similar secretion 
patterns for HMGB1 and IL1B following CQ and GW4869 
treatments (Figure 8E). BMDM cells also showed decreased 
HMGB1 secretion following GW4869 treatment (Figure 8F). 
Additionally, GORASP2-deficient mouse BMDMs showed 
reduced HMGB1 secretion upon LPS treatment (Figure 8G). 
Treatments used in our study did not significantly affect cell 
death when treated to immune cells (Fig. S7). These data 
demonstrate that HMGB1 secretion is regulated by the auto-
phagy machinery and MVB formation.
Physiological relevance and proposed model of HMGB1 
secretion
We examined the role of GORASP2-autophagy-dependent 
HMGB1 secretion in vivo. C57BL/6 WT and gorasp2−/- 
mice were injected intraperitoneally with a sublethal dose 
of LPS (2 mg/kg). Blood samples were collected at 16 h, 
and HMGB1 concentration in serum was measured. The 
HMGB1 secretion level was significantly decreased in 
gorasp2−/- mice compared to that in WT mice after LPS 
injection (Figure 9A).
To test whether HMGB1 secreted by the GORASP2- 
autophagy machinery and MVB-mediated pathway regulates 
inflammation, the culture supernatants from WT MEF, 
hmgb1−/- MEF, and atg5−/- MEF cells, which were treated with 
H2O2 or CQ in the presence or absence of GW4869, were 
harvested and used to treat RAW264.7 cells for TNF and IL6 
production. Levels of TNF and IL6 were significantly 
decreased upon treatment with supernatants from hmgb1−/- 
MEF or atg5−/- MEF cells (Figure 9(B,C)).
In summary, we propose a model of HMGB1 secretion 
mediated by HSP90AA1, GORASP2, the autophagy machin-
ery, and MVB (Figure 9D). Nuclear HMGB1 is translocated 
to the cytoplasm by HSP90AA1 and XPO1. Furthermore, 
post-translational modifications of HMGB1, such as oxida-
tion, helps its binding to XPO1 [27,48]. Cytoplasmic 
HMGB1 activates autophagy [48–50], and this autophagy 
activation induces the extracellular secretion of HMGB1. 
The autophagy machinery ATG5, ATG7, ATG12, and 
ATG14, and GORASP2 are involved in the packaging of 
cytosolic HMGB1 into phagophores. When the fusion of 
autophagosomes and lysosomes is blocked, HMGB1 secre-
tion is increased through the MVB-dependent secretion 
pathway. RAB8A-, RAB11A-, or RAB27A-mediated vesicle 
trafficking regulates HMGB1 secretion. The pro- 
inflammatory cytokines IL1B and IL18 also lack signal pep-
tides and are secreted through an unconventional secretion 
pathway after inflammasome activation [51,52]. IL1B and 
IL18 are secreted by the GORASP2-dependent autophagy 
pathway [17,18].
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Discussion
Understanding the mechanism of HMGB1 secretion is crucial 
since extracellular HMGB1 plays pro-inflammatory functions as 
a danger-associated molecular pattern molecule, including reg-
ulation of cell proliferation, tissue remodeling, and cancer pro-
gression [3,4]. Several active secretion mechanisms of HMGB1 
have been reported, including those mediated by secretory lyso-
somes and autophagy. ATG5, ATG7, and ATG12 regulate 
HMGB1 secretion [6,17]. Moreover, HMGB1 post- 
translational modifications, including acetylation, methylation, 
are involved in the secretion [8,12]. We previously reported that 
HMGB1 phosphorylation, N-glycosylation, and intramolecular 
disulfide bond formation between C23 and C45 play critical 
roles in HMGB1 nucleo-cytoplasmic transport and secretion 
[7,9,27]. HMGB1 lacks an ER-targeting peptide sequence; thus, 
it requires the unconventional secretion pathway as an ER-Golgi 
-independent route of secretion involving vesicular trafficking. 
Many proteins, such as DBI/ACBP/AcbA (diazepam binding 
inhibitor, acyl-CoA binding protein), IL1B, CFTRΔF508, and 
ANXA2, which are known to be secreted via an unconventional 
secretion pathway, utilize autophagy components for their secre-
tion [17,39,44,53,54].
In this study, we demonstrated, for the first time, that HMGB1 
secretion is regulated by HSP90AA1 and a GORASP2-mediated 
autophagy-based secretion machinery and the formation of 
MVBs. HMGB1 is mainly located in the nucleus, and 
HSP90AA1-dependent trafficking is involved in nucleo- 
cytoplasmic translocation of HMGB1. Overexpressed 
HSP90AA1 binds to nuclear HMGB1, resulting in XPO1- 
mediated nucleo-cytoplasmic export of HMGB1. HSP90AA1 
plays important roles in nuclear import or export of cargo pro-
teins. In a study of AGO1 (argonaute RISC component 1), 
a silencing effector protein in plants, HSP90AA1 was found to 
bind to AGO1 in the nucleus and induce nucleo-cytoplasmic 
shuttling via XPO1 [55], which is similar to HMGB1 transloca-
tion. However, the mineralocorticoid receptor, a member of the 
steroid receptor superfamily, is imported into the nucleus in 
complex with HSP90AA1 [56]. Interestingly, HSP90AA1 facil-
itates the translocation of cargo proteins in both directions across 
the nuclear membrane. HSPA7 migrates to the nucleus under cell 
stress caused by H2O2 and interacts with HMGB1 to inhibit the 
cytoplasmic translocation of HMGB1 [26]. The HSP90AA1 and 
HSPA7 chaperones bind to each other and function synergisti-
cally in protein remodeling [57]. Further studies on how 
HSP90AA1 leads HMGB1 to expose the nuclear export signal 
to bind XPO1 by interaction with HMGB1 are necessary.
When HMGB1 is translocated into the cytoplasm, the auto-
phagy machinery and vesicular trafficking are required for 
HMGB1 secretion. HSP90AA1 enhances the autophagy 
machinery and vesicular trafficking secretion, similarly to IL1B 
secretion [17,24,58]. atg5−/- MEF cells showed significant inhi-
bition of HMGB1 secretion even under starvation stress, con-
firming that HMGB1 is contained in autophagosomes. Baf and 
CQ treatments to inhibit autolysosome formation promoted 
HMGB1 secretion. These results suggest that autophagosome 
formation is important in HMGB1 secretion. GORASP2 defi-
ciency and SAR1AT39N and ARF1Q71L DN mutants inhibited 
ER-to-Golgi vesicular trafficking and increased autophagosome 
formation, resulting in UCPS [36,37,39] and HMGB1 secretion. 
In patients with cystic fibrosis, CFTRΔF508 (a cystic fibrosis 
transmembrane conductance regulator mutant containing 
a phenylalanine deletion at position 508), which is the most 
common mutant form of CFTR, was transported to the cell 
membrane via an unconventional secretion pathway during 
cellular stress [36,37,39]. These findings could suggest that 
UCPS of not only transmembrane proteins, such as the 
CFTRΔF508 mutant but also cytosolic proteins, including 
HMGB1, is increased by autophagosome formation increased 
by blocking the conventional ER-to-Golgi secretion pathway.
In this regard, an interesting finding is that the type III UCPS 
of HMGB1 secretion exhibits some similarities to the type IV 
UCPS of CFTR and SLC26A4. The present study demonstrates 
that ER-to-Golgi blockade by SAR1A and ARF1 mutants, early 
autophagy components, and RAB8A are involved in the UCPS 
of HMGB1 and are also known to play a role in the UCPS of 
CFTR and SLC26A4 [59]. In contrast, in the case of HSP pro-
teins, there are also some discrepancies between the type III and 
type IV UCPS pathways. While HSP90AA1 is involved in the 
type III UCPS of IL1B and HMGB1, HSPA8/HSC70 plays 
a critical role in the type IV UCPS of CFTR and SLC26A4 
[37]. Therefore, it appears that both type III and IV vesicular 
UCPS pathways share conventional machinery after a certain 
step, although initial cargo requirements mediated by HSPs are 
differently achieved.
In exosome biogenesis, autophagy machinery contributes to 
exosome biogenesis. The ATG12–ATG5-ATG16L1 complex 
localizes to MVBs and mediates the non-canonical lipidation of 
LC3B. The ATG5-ATG16L1 complex also facilitates the disso-
ciation of V-ATPase, preventing the acidification of MVBs and 
their subsequent lysosomal degradation [60]. In our study, inhi-
bition of RAB11 and RAB8A or RAB27A reduced HMGB1 
secretion. RAB11 is involved in the formation of amphisomes, 
which are autophagic vacuoles obtained upon the fusion of 
MVBs and autophagosomes, and both RAB8A and RAB27A 
help amphisomes fuse with the plasma membrane. The forma-
tion of amphisomes by the fusion of autophagosomes and MVBs 
is an important step in HMGB1 secretion. Inhibition of ESCRT 
prevented HMGB1 secretion, and treatment with GW4869, 
which inhibits ceramide-dependent MVB formation, prevented 
the extracellular secretion of HMGB1, supporting this mechan-
ism. However, how the fate of proteins is determined by distin-
guishing between degradative- and secretory autophagy using 
the same autophagy machinery remains unclear.
HMGB1 secretion is closely related to not only inflammatory 
diseases but also to various other diseases, including cancer, 
ischemia-reperfusion injury, Alzheimer’s disease, and heart fail-
ure [61–68]. The abovementioned results, thus, contribute to 
the understanding of the sequential regulation of the HMGB1 
secretion pathway, which may be useful for designing inhibitors 
of HMGB1 secretion for treating conditions, such as sepsis.
Materials and methods
Cell culture and reagents
HEK293T cells (ATCC®, CRL-1573™), BMDMs, murine 
macrophage RAW264.7 cells (ATCC®, TIB-71™), Tet-off 
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inducible atg5−/- MEF cells, and atg14−/- HCT116 cells [69] 
were cultured in Dulbecco’s modified Eagle’s medium 
(Corning, 10–013-CV). Human monocyte THP-1 cells 
(ATCC® TIB-202™) were cultured in RPMI1640 supplemented 
with 10% fetal bovine serum (Corning, 35–015-CV), 100 U/ 
mL penicillin, 100 μg/mL streptomycin, and 2 mM 
L-glutamine (GibcoTM, 10,378,016) at 37°C under 5% CO2. 
Mouse BMDMs were supplemented with 20% L929 condi-
tioned media. atg5−/- MEFs were maintained with 1 μg/mL 
doxycycline hyclate (Sigma-Aldrich, D9891). For THP-1 dif-
ferentiation, the cells were treated with 500 nM PMA for 5 h. 
For cell starvation, the cells were cultured in the EBSS med-
ium (Welgene, LB002-03). The cells were treated with differ-
ent concentrations of GA (Sigma-Aldrich, G3381), CQ 
(Sigma-Aldrich, C6628), Baf (Sigma-Aldrich, B1793), Wort 
(Sigma-Aldrich, W1628), PMA (Sigma-Aldrich, P1585), TSA 
(Sigma-Aldrich, T8552), LMB (Sigma-Aldrich, L2913), 
GW4869 (Sigma-Aldrich, D1692), LPS (E. coli O111:B4; 
Sigma-Aldrich, L5293), and H2O2 (Sigma-Aldrich, H1009) to 
observe HMGB1 secretion.
Mice
C57BL/6 WT and gorasp2−/- mice were used [70]. Mice were 
maintained under pathogen-free conditions and a 12:12 h 
light-dark cycle. Experiments were performed on randomly- 
selected, age- and gender-matched, 8- to 12-week-old male 
mice, according to procedures approved by the Institutional 
Animal Care and Use Committee of the Yonsei Laboratory 
Animal Research Center (YLARC, 2018–0293).
Plasmids, cloning, shRNA construct, and transfection
cDNA of HSP90AA1 was subcloned into the pFlag CMV2 
plasmid (Creative Biogene, VET1147). The HSP90AA1 
domain mutants NTD (a.a. 1–271), MD (a.a. 272–629), and 
CTD (a.a. 630–732) were inserted into the pFlag TOPO plas-
mid (MGmed, Seoul, Korea, MC02204). Construction of 
GORASP2-MYC, MYC-SAR1AT39N, and HA-ARF1Q71L plas-
mids were described previously [39]. MYC-tagged HMGB1 
WT, A and B boxes, WT GFP-HMGB1, and GFP- 
HMGB1C23S were described previously [11]. The cDNA of 
HMGB1 was sub-cloned into the pGmC plasmid (kindly 
provided by Prof. Seung Woo Park, Yonsei University 
College of Medicine, Seoul) to prepare the HMGB1-mCherry 
plasmid. An HMGB1 C-tail deletion mutant (HMGB1 ΔC, a.a. 
1–185) was prepared in the pCMV-MYC plasmid (Clontech, 
631,604). The cDNA of MAP1LC3B/LC3B was sub-cloned 
into the pEGFP-N1 plasmid (Clontech, 6085–1).
shRNA plasmids of control (SHC001), HSP90AA1 
(TRCN0000315007 and TRCN0000315009), GORASP2 
(TRCN0000129348 and TRCN0000127611), RAB7A 
(TRCN0000229643), RAB8A (TRCN0000048216), RAB11A 
(TRCN0000073021), RAB27A (TRCN0000005295), and HGS 
(TRCN0000379833), ATG7 (TRCN0000007584 and 
TRCN0000007585), ATG12 (TRCN0000272775 and 
TRCN0000272776), ATG14 (TRCN0000144080 and 
TRCN0000121630), and TSG101 (TRCN0000315042) pro-
duced at the BROAD Institute (Cambridge, MA, USA) were 
purchased from Yonsei Genomics Center System Biology 
Core (Yonsei Univ., Seoul, Korea).
Plasmid transfection was carried out using the lipofecta-
mine 2000 reagent (Invitrogen, 52,887) or the Neon transfec-
tion system (Invitrogen, MPK10096) for electroporation, 
according to the manufacturer’s instructions. shRNA was 
transiently transfected into HEK293T cells using the lipofec-
tamine 2000 reagent.
Western blot analysis and IP
For immunoblotting, the cells were lysed with 1× RIPA buffer 
(GenDEPOT, R4100-010) containing 150 mM NaCl, 1% 
Triton X-100 (Sigma-Aldrich, 9002–93-1), 1% deoxycholic 
acid sodium salt (Sigma-Aldrich, 264,101), 0.1% SDS (Sigma- 
Aldrich, 152–21-3), 50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 
and a protease inhibitor cocktail (GenDEPOT, P3100). WCLs 
were centrifuged at 20,000 × g for 10 min at 4°C. Culture 
supernatants were concentrated using an Amicon Centricon 
filtration system (Millipore, UFC501096) after removing cell 
debris. Protein sample buffer [100 mM Tris-HCl, pH 6.8, 2% 
SDS, 25% glycerol (Biosesang, G1018), 0.1% bromophenol 
blue, and 5% beta-mercaptoethanol (Amresco, 0482)] was 
added to the WCLs followed by heating at 94°C for 5 min, 
and 20 μg of protein was separated by SDS-PAGE followed by 
transfer to nitrocellulose membranes (GE healthcare, 
10,600,001) for immunoblotting. The membranes were 
blocked with Tris-buffered saline (TBS; 150 mM KCl, 
50 mM Tris, 1 mM EDTA, pH 7.4) supplemented with 0.1% 
Tween 20 (VWR Life Science, 0777), and 5% skim milk (BD 
Difco, 232,100) for 1 h. Anti-HMGB1 (Abcam, ab18256), 
anti-GORASP2 (Abcam, ab68713), anti-HSP90 (Abcam, 
ab13492), anti-XPO1/CRM1 (Santa Cruz Biotechnology, SC- 
5595), anti-GFP (Santa Cruz Biotechnology, SC-8334 and SC- 
9996), anti-GORASP1/GRASP65 (Santa Cruz Biotechnology, 
SC-374,423), anti-GAPDH (Abfrontier, YF-MA10022), anti- 
ACTB/β-actin (Cell Signaling Technology, 4967), anti-MYC 
/c-Myc (Invitrogen, 13–2500), anti-LC3B (Sigma-Aldrich, 
L7543), anti-Flag (Sigma-Aldrich, F3165 and F7425), anti- 
PDCD6IP/Alix (Abcam, ab117600), anti-HGS (Abcam, 
ab155539), anti-ATG5 (Novus, NB110-53,818), anti-ATG12 
(Cell Signaling Technology, #4180), anti-ATG14 (MBL inter-
national, PD026), anti-TSG101 (Santa Cruz Biotechnology, 
SC-7964), anti-CASP1/caspase1 (AdipoGen, AG-20B-0042), 
and anti-IL1B/IL-1β (R&D Systems, AF-401-NA) antibodies 
were used. The membranes were washed with TBS-Tween 20 
three times for 10 min each and incubated with the proper 
horseradish peroxidase-conjugated secondary antibody 
(Jackson ImmunoResearch, 111–035-003 and 111–035-003) 
for 1 h, and washed three times for 10 min each with TBS- 
Tween 20. Enhanced chemiluminescent substrate 
(GenDEPOT, W3651-012) was used for visualization. The 
membranes were then stripped by submersion in stripping 
buffer (Biomax, BWS-1000) at room temperature for 20 min 
under constant shaking.
IP was performed using 15 μL of SureBeads™ Protein 
G Magnetic Beads (BIO-RAD, 161–4023). The beads were 
washed three times with PBST buffer using DynaMagTM-2 
(Invitrogen, 123.21D) and incubated with 1 μg of a specific 
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antibody for 1 h at RT. The beads were washed three times 
with PBST, and 300 μg of protein was added to the beads for 
overnight rotation at 4°C. The samples were washed three 
times with PBST and then mixed with a protein sample 
buffer, followed by heating at 94°C for 5 min. The proteins 
were separated by SDS-PAGE.
Immunofluorescence and confocal microscopy
To detect the subcellular localization of HMGB1 under star-
vation conditions or LMB treatment, HEK293T cells were 
transfected with WT GFP-HMGB1 or GFP-HMGB1C23S plas-
mid with or without WT HSP90AA1-Flag or its mutant plas-
mids (NTD, MD, and CTD) or GORASP2-MYC for 48 h. The 
cells were pretreated with 0.5 μM GA for 2 h and incubated 
with EBSS for 6 h or treated with 20 ng/mL LMB for 24 h in 
HEK293T cells. Cells were washed with cold PBS, fixed with 
4% paraformaldehyde-PHEM buffer (Biosesang, PC2031-100- 
00) for 30 min at room temperature, and then washed with 
cold PBS.
To observe HMGB1 and LC3 co-localization upon 
HSP90AA1 and GORASP2 overexpression, HEK293T cells 
were transfected with HMGB1-mCherry, GFP-LC3, and 
GORASP2-MYC or HSP90AA1-Flag and incubated for 48 h. 
Cells were treated with 20 μM CQ under EBSS for 4 h. After 
washing with cold PBS, the cells were treated with 20 μg/mL 
digitonin (Millipore, 300,410) on ice for 5 min to remove 
cytosolic protein. The cells were immediately washed with 
cold PBS, fixed with 4% paraformaldehyde-PHEM buffer for 
30 min at room temperature, and washed with cold PBS.
For cell permeabilization, the cells were washed with PBS 
containing 1% Triton X-100 for 10 min, followed by washing 
with PBS containing 0.02% Tween 20 for 5 min. To block 
nonspecific antibody binding, the cells were treated with PBS 
containing 0.02% Tween 20 and 1% bovine serum albumin 
(BSA) for 5 min. The cells were incubated in PBS containing 
3% BSA and anti-Flag and anti-MYC antibodies overnight at 
4°C in a humidified chamber. The cells were removed from 
the solution and washed with 1% BSA in PBST (0.02% Tween) 
for 5 min. The cells were then incubated with Alexa Fluor 
405- and Alexa Fluor 594-conjugated secondary antibodies 
(Invitrogen, A31553 and A32740) in the dark for 1 h at 37° 
C. The cells were finally washed with PBST and mounted with 
or without 4 or 6′-diamidino-2-phenylindole (DAPI; 
Vectashield, H-1200 and H-1000), and the fluorescence of 
the cells was measured using a confocal FV1000 microscope 
(Olympus).
PLA
To observe the interaction between HMGB1 and HSP90AA1 in 
cells, MYC-HMGB1 and HSP90AA1-Flag were transfected into 
HEK293T cells on LabTek chamber slides (Nunc, C6807). After 
48 h of incubation, the cells were incubated in starvation media 
for 4 h and fixed with 4% paraformaldehyde-PHEM buffer for 
30 min at room temperature. The cells were sequentially washed 
with 1% Triton X-100, 0.02% Tween 20, and 0.02% Tween 20 
plus 1% BSA in PBS. The PLA was performed using a Duolink- 
in-Situ kit (Sigma-Aldrich, DUO92101) following the 
manufacturer’s instructions. Briefly, the cells were treated with 
anti-HMGB1, anti-HSP90AA1, anti-MYC, and anti-Flag anti-
bodies overnight at 4°C, followed by washing. The cells were 
incubated with a PLA probe mixture and ligation solution at 37° 
C. For signal amplification, the cells were incubated in poly-
merase solution at 37°C. After staining with DAPI, fluorescence 
was visualized under a confocal microscope.
ELISA
Polystyrene microplates (Costa, 3590) were coated with recom-
binant HSP90AA1 (ATGen, ABIN806289) diluted in carbonate- 
bicarbonate buffer (pH 9.6) at 4°C for 18 h and then washed 
three times with PBST. The wells were blocked with PBST 
containing 3% BSA at 37°C for 2 h. Recombinant HMGB1 
was serially diluted in 3%-PBST and added to the wells for 1 h 
at 37°C. After washing, the anti-HMGB1 antibody was added to 
each well for incubation for 1 h at 37°C. Horseradish perox-
idase-conjugated goat anti-rabbit IgG was added for 30 min at 
37°C. Next, 3,3,5,5ʹ-tetramethylbenzidine (TMB; Invitrogen, 
002023) substrate was added, and the reaction was stopped by 
adding 3 N HCl. The optical density was read at 450 nm.
To measure TNF production, RAW264.7 cells were pre-
treated with 100 nM Wort, 20 nM Baf, 25 μM CQ, and 2 μM 
GW4869 for 2 h and then treated with 250 ng/mL LPS or 
50 μM H2O2 for 24 h. The mouse TNF level was measured 
using a mouse TNF ELISA kit (Invitrogen, 88–7324-88).
Mass spectrometry
HEK293T cells were transfected with the MYC-HMGB1 plas-
mid and then lysed with 1× RIPA buffer. MYC affinity beads 
(Biotool, B23401) were used for the affinity-isolation assay at 
4°C for 24 h. The samples were washed three times with cold 
PBS, and then the protein sample buffer was added for incu-
bation at 94°C for 5 min. The samples were separated by SDS- 
PAGE. The gels were stained by the Coomassie Brilliant Blue 
staining method, and protein bands of interest were cut from 
the gel. Nano liquid chromatography-tandem mass spectro-
metry (MS/MS)–analysis was performed using a nano HPLC 
system (Agilent Technologies). The nanochip column 
(Agilent, 150 × 0.075 mm) was used for peptide separation. 
The mobile phase A for liquid chromatography separation 
was 0.1% formic acid in deionized water, and the mobile 
phase B was 0.1% formic acid in acetonitrile (ThermoFisher, 
85,174). The chromatography gradient involved a linear 
increase from 3% B to 40% B in 80 min, 40% B to 60% B in 
10 min, 95% B in 10 min, and 3% B in 20 min. The flow rate 
was maintained at 400 nL/min. Product ion spectra were 
collected in information-dependent acquisition mode and 
analyzed by Agilent 6530 Accurate-Mass Q-TOF using con-
tinuous cycles of one full scan time-of-flight MS from 
350–1200 m/z (1.0 s) plus three product ion scans from 
100–1700 m/z (1.5 s). Precursor m/z values were selected, 
starting with the most intense ion, using a selection quadru-
pole resolution of 4 Da. The rolling collision energy feature 
was used, which determines the collision energy based on the 
precursor value and charge state. The dynamic exclusion time 
for precursor ion m/z values was 30 s.
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EV preparation and proteinase protection assay
EVs were purified according to differential centrifugation pro-
tocols, with slight modification [71]. WT BMDM and gorasp2−/- 
BMDM from C57BL/6 were seeded in culture dishes in com-
plete DMEM containing 8% L929 culture supernatant, at 
approximately 70% confluence. After washing with DPBS 
(Gibco, A1285801), the cells were incubated in OPTI-MEMTM 
(Gibco, 31,985,088) with 250 ng/mL LPS for 24 h. In WT MEF 
and atg5−/- MEF cells were washed with DPBS and incubated in 
EBSS medium for 14 h with 20 nM Baf and 20 μM CQ. The 
supernatants were harvested and centrifuged at 300 × g for 
10 min to remove the cell debris. The supernatants were cen-
trifuged at 2,000 × g for 20 min to remove apoptotic bodies and 
then at 10,000 × g for 30 min to remove large particles. Finally, 
the supernatants were ultracentrifuged at 100,000 × g for 2 h, 
and the pellets (EVs) were resuspended in DPBS. Protein con-
centration was measured using the BCA protein assay kit 
(Thermo Fisher Scientific, 23,225). The same amount of EVs 
from each sample was incubated with 20 μg/mL proteinase 
K (New England BioLabs, P8107S), with or without 1% Triton 
X-100, for 1 h at 37°C. The reaction was stopped by adding 
2× protein sample buffer, and the lysates were immunoblotted.
Cytokine production
WT MEF, hmgb1−/- MEF, and atg5−/- MEF cells were seeded 
in 12-well plates in complete DMEM, at approximately 70% 
confluence. After washing twice with DPBS, the cells were 
pretreated with or without 2 μM GW4869 for 2 h and then 
treated with 50 μM H2O2 and 30 μM CQ for 24 h in EBSS 
medium. The culture supernatants were collected, and cell 
debris was removed by centrifugation. To observe the effect 
of cytokine production by each culture supernatant, 
RAW264.7 cells were cultured at a density of 5 × 105 cells/ 
mL in 24-well plates in OPTI-MEM medium and treated with 
the collected supernatant at a 1:10 ratio for 6 h. Culture 
supernatants were harvested by centrifugation at 
2,000 × g at 4°C. Concentrations of TNF and IL6 were mea-
sured using sandwich ELISA (R&D System, DY410, and 
DY206), according to the manufacture’s protocol.
Database searching
The mascot algorithm (Matrix Science) was used to identify 
peptide sequences present in a protein sequence database. 
HMGB1 (CAG33144.1), Homo sapiens (downloaded 
21 September 2016) fixed modification; carbamidomethylated 
at cysteine residues; variable modification; oxidized at methio-
nine residues; maximum allowed missed cleavage; 2, MS tol-
erance; 100 ppm, MS/MS tolerance; 0.1 Da. Only peptides 
resulting from trypsin digests were considered.
Statistical analysis
All data are presented as the mean ± SEM of at least three 
individual measures. In particular, co-localization of HMGB1 
and HSP90AA1 or HMGB1 and LC3 was analyzed using the 
ImageJ software (NIH) by Manders’ coefficients method. 
Statistical analyses were performed using one-way analysis of 
variance with the Tukey honestly significant difference posthoc 
test for multiple comparisons or two-tailed Student’s t-test for 
comparisons between two groups using the GraphPad Prism 5 
software (GraphPad Software). Differences were considered 
statistically significant when p < 0.05.
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